- Capital Cube•24 days ago
Click here to see latest analysis*Disclaimer : This is as of previous day’s closeETF’s with exposure to Aratana Therapeutics, Inc.Here are 5 ETF’s with the largest exposure to PETX-US. Comparing the performance and risk of Aratana Therapeutics, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us […] (Read more...) The post ETF’s with exposure to Aratana Therapeutics, Inc. : July 1, 2016 appeared first on CapitalCube.
- American City Business Journals•25 days ago
The Leawood-based animal health company has filed an administrative New Animal Drug Application with the Food and Drug Administration's Center for Veterinary Medicine for the drug Nocita. The therapeutic is administered as a single dose by tissue infiltration during closure of torn knee ligament surgery in dogs. Aratana has received two FDA approvals so far this year, and this application is the company's third.
Aratana Therapeutics, Inc.NasdaqGM
After hours: 6.450.00 (0.00%) as of 4:31 PM EDT
|Bid||6.15 x 5000|
|Ask||7.50 x 200|
|52wk Range||2.56 - 19.99|
|Day's Range||6.35 - 6.57|
|Avg Vol (3m)||625,996|
As of 4:00 PM EDT. Market closed.